ALNY

Alnylam Pharmaceuticals

Fundamental data last updated:April 13, 2026

company profile

SECTOR

Healthcare

industry

Biotechnology

Exchange

Nasdaq

County of HQ

United States

Next Earnings Date

05/07/26

Business Summary

Leonardo DRS operates as a defense electronics and systems provider, generating revenue through long-cycle government contracts tied to military modernization programs. Cash flow is driven by engineered systems, sensing technologies, and integrated defense platforms embedded within broader defense procurement budgets. The moat stems from entrenched relationships, regulatory barriers, and qualification-heavy defense supply chains that limit new entrants. Recurring program funding and mission-critical integration create stickiness, allowing the company to convert specialized engineering capabilities into durable contract revenue streams.

VALUATION

P/E

138.9

Market Cap ($M USD)

$42,978

Forward P/E

22.7

PEG

0.7

PRICE TO SALES

11.7

PRICE TO BOOK

54.4

EV / EBITDA

65.5

5-Year Average P/E

DIVIDEND

Yield

-

Annual Payout

-

Payout Ratio

-

Consecutive Years of Dividend Growth

0

5-Year Dividend Growth Rate

-

Financial Health & Profitability

Earnings Per Share

$2.39

Next Year EPS Growth Estimate

$14.20

Next Year Revenue Growth Estimate

30.00%

Return on Equity (ROE)

39.80%

Operating Margin

13.50%

Debt-to-Equity

1.6

Piotroski F-Score

6

Altman Z-Score

6

Return on Invested Capital (ROIC)

26.30%%

Current Ratio

2.8

Quick Ratio

Gainseekers Quantitative Analysis

Summary

At 44.6x earnings and 32.7x forward earnings, DRS Leonardo DRS is not priced like a bargain—it is priced like a growth compounder. A PEG Forward of 1.6 suggests growth is reasonably aligned with valuation but hardly screaming cheap, especially with Return on Equity at just 6.50%. However, the Altman Z-Score of 4.80 signals strong financial stability and low bankruptcy risk, meaning the balance sheet risk is minimal. The market is not mispricing this as distressed—it is paying up for stability and moderate forward growth, and the compression from 44.6 P/E to 32.7 Forward P/E implies anticipated earnings acceleration, though not hypergrowth.

AI Exposure / Tech Reliance

As part of the Aerospace & Defense industry, DRS operates in a sector inherently tied to advanced electronics, sensing systems, and defense modernization—all areas increasingly influenced by AI-driven analytics and autonomous systems. The Industrials sector is steadily integrating AI into command, control, and surveillance frameworks, positioning companies in this space to benefit from defense digitization. The valuation premium implies investors expect this technological integration to support sustained earnings expansion.

The Bull Case

A GARP investor can justify ownership here on quality and stability metrics rather than deep value optics. The Piotroski F-Score of 6 indicates fundamentally sound operations without major deterioration signals, while ROIC of 9.20% shows the company is generating returns above capital costs at a respectable level for an industrial defense name. Operating Margin of 10.20% demonstrates disciplined cost structure in a capital-intensive industry, and a Current Ratio of 1.9 supports near-term liquidity strength. Institutional Ownership at $51.40 suggests meaningful professional sponsorship, and the drop from 44.6 P/E to 32.7 Forward P/E paired with a PEG of 1.6 gives a credible growth-adjusted justification rather than speculative excess.

The Bear Case

The red flags are valuation tension and capital efficiency. A 44.6 P/E against 6.50% ROE is not compelling—investors are paying a premium multiple for middling equity returns. Debt / Equity at 9.50% is modest, but the Price / Book of 4.5 indicates the market is valuing the equity base aggressively relative to accounting capital. With a TTM Yield of 0.2 and Dividend Per Share USD of 0.80% alongside a Payout Ratio of $0.36, income support is negligible, meaning downside protection relies almost entirely on earnings growth materializing as implied by the 32.7 Forward P/E and 1.6 PEG. If growth disappoints, multiple compression risk is significant.

Market Sentiment & Smart Money

Short Interest %

4.30%

Analyst Consensus

1.7

Average Analyst Price Target

$450.43

Institutional Ownership %

101.10%

1-Year Beta

0.71

Insider Buying % (6 Mo)

0.20%%

Distance to 52-Week High

65.00%%

Distance to 52-Week Low

146.10%%